ZEAL stock: buy or sell?

ZEAL stock price: $21.05 3.90% At close on May 21st, 2019

Updated on:
May 21st, 2019


Zealand Pharma A/S closed today at $21.05 after topping to a new all time high ($21.12) and boosted a phenomenal 3.90%.

Zealand Pharma A\u002FS, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark.

Should I buy ZEAL stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, 2 buy setups are elegible for Zealand Pharma A/S stock right now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is Zealand Pharma A/S stock a buy?

Financial institutions and banks post stock ratings everyday. At Stocks2.com, we found 1 rating published for ZEAL stock in the last 30 days.

Is ZEAL a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-3-7Needham & Company LLCn/aBuy

ZEAL stock analysis

Daily outlook

Zealand Pharma A/S boosted 3.90% today and topped a new all time high at $21.12.

Zealand Pharma A/S boosted 3.90% to $21.05 after topping to all time highs today. Since last Apr/23 when SMA100d and SMA200d crossed up, ZEAL price gained $2.75 per share (15.03%). Since last February when ZEAL stock price broke up the SMA200d line, it gained $6.75 (47.20%). ZEAL broke out again over $20.85 after a 5.08% correction started on May/14.

ZEAL stock chart (daily)

Weekly outlook

Zealand Pharma A/S topped new all time highs again this week, setting highs to $21.12. Shares closed at $21.05 and skyrocketed 6.05% during the week. Early April ZEAL collapsed a hair-raising -6.09% in just one week.

Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $14.72 resistance. Early April, SMA20w and SMA40w crossed up triggering a rise of 9.81%. Since price and SMA40w lines crossed up late January, ZEAL climbed $7.01 (49.93%).

ZEAL stock chart (weekly)

ZEAL stock price history

ZEAL stock went public on August 9th, 2017 with a price of $18.121. Since then, ZEAL stock grew a 16.20%, with an average of 16.20% per year. If you had invested right after ZEAL's IPO a $1,000 in ZEAL stock in 2017, it would worth $162.00 today.

1: Adjusted price after possible price splits or reverse-splits.

ZEAL stock historical price chart

ZEAL stock reached all-time highs today with a price of $21.12.

ZEAL stock price target is $29.00

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we only found 1 price prediction for Zealand Pharma A/S stock:
ZEAL stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-3-7Needham & Company LLCReiteratesn/a$29.00-
(in average)$0.00$29.000.0%

Financials and fundamental analysis

Earnings date and Earnings per Share

Zealand Pharma A/S let down experts on March when it published an Earnings per Share (EPS) of $-0.61 when the analysts' forecast was $-0.69.
ZEAL earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Zealand Pharma A/S annual revenues plunged a scary -72.14% to $37.98 million dollars from $136.32 marked in 2017. When comparing 2018 vs 2017, instead, profit margin (that is, the net income divided by revenues) skyrocketed a 1,732.53% to 1,530.62%.

ZEAL annual Sales and Income evolution
2013$6.57 M-$-183.68 M-2795.7%-
2014$154 M2,240.53%$-64.99 M-42.3%-64.62%
2015$188 M22.05%$-113.96 M-60.7%75.35%
2016$235 M25.10%$-153.91 M-65.6%35.06%
2017$136 M-41.94%$-275.26 M-201.9%78.84%
2018$38 M-72.14%$581 M1530.6%-311.18%

Quarterly financial results

Zealand Pharma A/S reported $13.12 M in sales for 2018-Q4, a inf% up compared to previous quarter. Reported quarter earnings marked $-122.97 M with a profit margin of -937.37%. Profit margin stayed steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Zealand Pharma A/S sales marked an amazing gain and boosted a 24.67%.
ZEAL quarterly Sales and Income evolution
2017-Q1$78 M-$-26 M-33.9%-
2017-Q2$11 M-86.09%$-94 M-867.4%255.79%
2017-Q3$6 M-41.44%$-7 M-105.5%-92.88%
2017-Q4$11 M66.39%$-111 M-1051.6%1,559.25%
2018-Q1$11 M2.91%$-91 M-844.1%-17.40%
2018-Q2$15 M39.77%$-127 M-840.1%39.12%
2018-Q4$13 M-13.33%$-123 M-937.4%-3.29%

Zealand Pharma A/S ownership

When you are planning to invest in shares of a company, it's always worth to overview its ownership structure.

Zealand Pharma A/S shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.00% of all shares.

In case of Zealand Pharma A/S stock, 9.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ZEAL stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related companies:

Market cap$646.0 M
Total shares30.7 M
Float shares24.5 M
  - Institutional holdings (%)9.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

ZEAL summary

Tuesday, May 21st, 2019
Day range$20.68 - $21.12
Previous close$20.26
Session gain3.90%
Average true range$0.51
50d mov avg$18.49
100d mov avg$16.08
200d mov avg$15.24
Daily patternlb01c
Weekly pattern lb02c

Zealand Pharma A/S performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Zealand Pharma A/S performance to :

Zealand Pharma A/S competitors

Unfortunately, we could not find any public company that could be defined as Zealand Pharma A/S competitor. This doesn't mean Zealand Pharma A/S does not have any competitor in the market, it's just we could not detected it.